Macular Corneal Dystrophy Type 1 Overview
Learn About Macular Corneal Dystrophy Type 1
The Johns Hopkins Hospital
John D. Gottsch, M.D., is the Margaret C. Mosher Professor of Ophthalmology at the Wilmer Eye Institute. Dr. Gottsch specializes in the management of hereditary corneal disorders such as Fuchs' dystrophy, the surgical treatment of cataract and complications of cataract surgery, and corneal transplantation surgery. His clinical practice involves the medical treatment of allergic eye diseases and severe corneal inflammation from rheumatoid and other related disorders, including Mooren''s ulcer. His research interests include determining the gene expression of the cornea and the genetic basis for hereditary corneal diseases such as Fuchs' dystrophy. Dr. Gottsch is rated as an Elite provider by MediFind in the treatment of Macular Corneal Dystrophy Type 1. His top areas of expertise are Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Corneal Dystrophy and Perceptive Deafness, Cataract, and Corneal Transplant.
The Johns Hopkins Hospital
Allen O. Eghrari, M.D., M.P.H., is director of the Dana Center for Preventive Ophthalmology at the Wilmer Eye Institute and associate professor of ophthalmology at the Johns Hopkins University School of Medicine. He specializes in cornea, cataract and external eye diseases at the Wilmer Eye Institute's locations in Baltimore and Belcamp, Maryland. Dr. Eghrari treats a wide range of eye conditions, with special interest in Fuchs' dystrophy, cataract surgery, cornea transplantation including Descemet Membrane Endothelial Keratoplasty, and Ebola-associated eye disease. Dr. Eghrari received his M.D. degree from the Johns Hopkins University School of Medicine and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He completed both residency training in ophthalmology and subspecialty fellowship in cornea and cataract surgery at the Wilmer Eye Institute. Dr. Eghrari is a recipient of the Claes Dohlman Society Fellowship Award, the ARVO/Alcon Early Career Clinician-Scientist Award, and the Research to Prevent Blindness Special Scholar Award. Dr. Eghrari is rated as an Elite provider by MediFind in the treatment of Macular Corneal Dystrophy Type 1. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Cataract, Corneal Transplant, and Cataract Removal.
Davis Ambulatory Surgical Center
Terry Kim is an Ophthalmologist in Durham, North Carolina. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Macular Corneal Dystrophy Type 1. His top areas of expertise are Corneal Dystrophy and Perceptive Deafness, Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, and Cataract. Dr. Kim is currently accepting new patients.
Summary: This protocol will investigate whether topical application of N-acetyl cysteine (NAC) eye drops decreases oxidative stress and confers cytoprotection in patients with FECD.
Summary: The purpose of this study is to evaluate the pharmacodynamics, safety, and tolerability of DT-168 Ophthalmic Solution in pre-keratoplasty patients with Fuchs endothelial corneal dystrophy.


